The role of marginal donors in liver transplantation. the Hungarian experience;Marginális donorok szerepe a magyar májátü ltetési programban

Orvosi Hetilap

Volumn 150, Issue 49, 2009, Pages 2228-2236

  Nemes, Balázs ^a   Gelley, Fanni ^a   Zádori, Gergely ^a   Görög, Dénes ^a   Fehérvári, Imre ^a   Jakab, Katalin ^a   Fazakas, János ^a   Mándli, Tamás ^a   Gerlei, Zsuzsa ^a   Sárváry, Eniko ^a   Doros, Attila ^a   Kóbori, László ^a  

^a II sz Sebeszeti Klinika   (Hungary)

Author keywords

Extended Donor Criteria; Liver transplantation; Marginal donor; Recurrence of Hepatitis C

Indexed keywords

EXTENDED DONOR CRITERIA; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HEPATITIS C; HUNGARY; LIVER GRAFT; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; ORGAN DONOR; REVIEW;

AGE FACTORS; BODY MASS INDEX; DONOR SELECTION; GRAFT SURVIVAL; HEPATITIS C; HUMANS; HUNGARY; HYPERNATREMIA; HYPOTENSION; INTENSIVE CARE UNITS; ISCHEMIA; LENGTH OF STAY; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; RECURRENCE; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 73949107725     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28743     Document Type: Review

References (46)

1. Steadman, R. H.: Anesthesia for liver transplant surgery. Anesthesiol. Clin. North America, 2004, 22, 687-711.
2. Schemmer, P., Nickkholgh, A., Hinz, U. es mtsai: Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis. Transplant. Proc., 2007, 39, 529-534.
3. Gorog D., Daboczi A., Toth A. es mtsai: Cadaver donorbol szarmazo maj elerhetosege Magyarorszagon. Orv. Hetil., 1996, 137, 2371-2373.
4. Eguchi, S., Takatsuki, M., Hidaka, M. es mtsai: Evolution of living donor liver transplantation over 10 years: experience of a single center. Surg. Today, 2008, 38, 795-800.
5. Kobori L., Mathe Z., Fazekas J. es mtsai: A gyermekkori majatultetes sebeszeti alapjai. Az el?donor-program els? lepesei Magyarorszagon. Orv. Hetil., 2008, 149, 1271-1275.
6. Yersiz, H., Cameron, A. M., Carmody, I. es mtsai: Split liver transplantation. Transplant. Proc., 2006, 38, 602-603.
7. Wilczek, H. E., Larsson, M., Yamamoto, S. es mtsa: Domino liver transplantation. J. Hepatobiliary Pancreat. Surg., 2008, 15, 139-148.
8. Alexander, J. W., Vaughn, W. K.: The use of .,marginal" donors for organ transplantation. The influence of donor age on outcome. Transplantation, 1991, 51, 135-141.
9. Renz, J. F, Kin, C., Kinkhabwala, M. es mtsai: Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann. Surg., 2005, 242, 556-563.
10. Merion, R. M., Pelletier, S. J., Goodrich, N. es mtsai: Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann. Surg., 2006, 244, 555-562.
11. Khapra, A. P., Agarwal, K., Fiel, M. I. es mtsai: Impact of donor age on survival and fi brosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl., 2006, 12, 1496-1503.
12. Lucidi, V., Lemye, A. C., Baire, L. es mtsai: Use of marginal donors for liver transplantation: a single-center experience within the Eurotransplant patient-driven allocation system. Transplant. Proc., 2007, 39, 2668-2671.
13. Cameron, A. M., Ghobrial, R. M., Yersiz, H. es mtsai: Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann. Surg., 2006, 243, 748-753.
14. Tector, A. J., Mangus, R. S., Chestovich, P. es mtsai: Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann. Surg., 2006, 244, 439-450.
15. Gruttadauria, S., Vizzini, G., Biondo, D. es mtsai: Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: a single-center experience. Liver Transpl., 2008, 14, 220-227.
16. Nemes B., Sarvary E., Kobori L. es mtsai: A hazai majatultetesi program demografi ai, perioperativ, es mortalitasi adatai. Orv. Hetil., 2005, 146, 1423-1432.
17. Fehervari I., Gorog D., Kobori L. es mtsai: Hepatitis B es majtranszplantacio. Orv. Hetil., 2007, 148, 1299-1302.
18. Nemes B., Zadori G., Hartmann E. es mtsai: Epeuti szovodmenyek majtranszplantacio utan. Orv. Hetil., 2008, 149, 963-973.
19. Uemura, T., Randall, H. B., Sanchez, E. Q. es mtsai: Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl., 2007, 13, 227-233.
20. Lopez-Navidad, A., Caballero, F.: Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin. Transplant., 2003, 17, 308-324.
21. Merion, R. M., Schaubel, D. E., Dykstra, D. M. es mtsai: The survival benefi t of liver transplantation. Am. J. Transplant., 2005, 5, 307-313.
22. Busuttil, R. W., Farmer, D. G., Yersiz, H. es mtsai: Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann. Surg., 2005, 241, 905-916.
23. Feng, S., Goodrich, N. P., Bragg-Gresham, J. L. es mtsai: Characteristics associated with liver graft failure: the concept of a donor risk index. Am. J. Transplant., 2006, 6, 783-790.
24. Hoofnagle, J. H., Lombardero, M., Zetterman, R. K. es mtsai: Donor age and outcome of liver transplantation. Hepatology, 1996, 24, 89-96.
25. Wynne, H. A., James, O. F.: The ageing liver. Age Ageing, 1990, 19, 1-3.
26. Halon, A., Patrzalek, D., Rabczynski, J.: Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? Transplant. Proc., 2006, 38, 193-195.
27. Strasberg, S. M., Howard, T. K., Molmenti, E. P. es mtsa: Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology, 1994, 20, 829-838.
28. Healey, P. J., Davis, C. L.: Transmission of tumours by transplantation. Lancet, 1998, 352, 2-3.
29. Nardo, B., Masetti, M., Urbani, L. es mtsai: Liver transplantation from donors aged 80 years and over: pushing the limit. Am. J. Transplant., 2004, 4, 1139-1147.
30. Ruhl, C. E., Everhart, J. E.: Epidemiology of nonalcoholic fatty liver. Clin. Liver Dis., 2004, 8, 501-519.
31. Rinella, M. E., Alonso, E., Rao, S. es mtsai: Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl., 2001, 7, 409-414.
32. Yoo, H. Y., Molmenti, E., Thuluvath, P. J.: The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl., 2003, 9, 72-78.
33. Alsharabi, A., Cieslak, B., Nyckowski, P. es mtsai: Biochemical assessment of the early liver graft function in relation to selected donor parameters. Transplant. Proc., 2003, 35, 2256-2259.
34. Totsuka, E., Dodson, F., Urakami, A. es mtsai: Infl uence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl. Surg., 1999, 5, 421-428.
35. Powner, D. J.: Factors during donor care that may affect liver transplantation outcome. Prog. Transplant., 2004, 14, 241-247.
36. Pokorny, H., Langer, F., Herkner, H. es mtsai: Infl uence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin. Transplant., 2005, 19, 532-536.
37. Mascia, L., Mastromauro, I., Viberti, S. es mtsai: Management to optimize organ procurement in brain dead donors. Minerva Anestesiol., 2009, 75, 125-133.
38. Nickkholgh, A., Weitz, J., Encke, J. es mtsai: Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol. Dial .Transplant., 2007, 22, viii29- viii36.
39. Cerutti, E., Stratta, C., Romagnoli, R. es mtsai: Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl., 2006, 12, 1253-1259.
40. Briceno, J., Solorzano, G., Pera, C.: A proposal for scoring marginal liver grafts. Transpl. Int., 2000, 13, S249-S252.
41. Montalti, R., Nardo, B., Bertelli, R. es mtsai: Donor pool expansion in liver transplantation. Transplant. Proc., 2004, 36, 520-522.
42. Busuttil, R. W., Tanaka, K.: The utility of marginal donors in liver transplantation. Liver Transpl., 2003, 9, 651-663.
43. Nemes B., Sarvary E., Gerlei Zs. es mtsai: Hepatitis C-virus kiujulasa majatultetes utan. Orv. Hetil., 2007, 148, 1971-1979.
44. Nemes B: A magyar majatultetesi program eredmenyeit befolyasolo egyes tenyezk, kulonos tekintettel a hepatitis C-virusra. PhD-vedes, Semmelweis Egyetem, Budapest, 2006.
45. Ferraz-Neto, B. H., Zurstrassen, M. P., Hidalgo, R. es mtsai: Donor liver dysfunction: application of a new scoring system to identify the marginal donor. Transplant. Proc., 2007, 39, 2516-2518.
46. Maluf, D. G., Edwards, E. B., Kauffman, H. M.: Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation, 2006, 82, 1653-1657.